SciVision Biotech Inc. (1786.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In TWD
| Market Cap | 5.26B |
| Enterprise Value | 4.9B |
| P/E Ratio | 26.8 |
| PEG Ratio | -1.71 |
| Price/Sales Ratio | 4.34 |
| Price/Book Ratio | 2.09 |
| Enterprise/Revenue | 4.24 |
| Enterprise/EBITDA | 16.12 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.16 |
| Operating Margin | 0.15 |
| Return On Assets | 0.06 |
| Return On Equity | 0.08 |
| Revenue | 886.62M |
| Revenue/Share | 12.09 |
| Gross Profit | 638.39M |
| EBITDA | 270.35M |
| Net Income | 162.34M |
| Diluted EPS | 2.24 |
| Total Cash | 871.11M |
| Total Cash/Share | 9.04 |
| Total Debt | 485.56M |
| Total Debt/Equity | 0.27 |
| Current Ratio | 2.29 |
| Book Value Per Share | 24.92 |
| 52-Week Change | -36.82 |
| 52-Week High | 87.5 |
| 52-Week Low | 38.8 |
| Moving Average 50 Days | 43.42 |
| Moving Average 200 Days | 55.48 |
| Average Volume | 407,816 |
| Shares Outstanding | 72.69M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1.91 |
| Trailing Annual Dividend Yield | 3.67 |
| Payout Ratio | 1 |
| Last Split Factor | 217:200 |
| Last Split Date | October 04, 2021 |